Aspirin and colorectal cancer prevention in Lynch syndrome.
作者信息
Chan Andrew T, Lippman Scott M
机构信息
Division of Gastroenterology, Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
出版信息
Lancet. 2011 Dec 17;378(9809):2051-2. doi: 10.1016/S0140-6736(11)61216-6. Epub 2011 Oct 27.
Abstract
摘要
相似文献
1
Aspirin and colorectal cancer prevention in Lynch syndrome.
Lancet. 2011 Dec 17;378(9809):2051-2. doi: 10.1016/S0140-6736(11)61216-6. Epub 2011 Oct 27.
2
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.
Lancet. 2020 Jun 13;395(10240):1855-1863. doi: 10.1016/S0140-6736(20)30366-4.
3
Does aspirin really reduce the risk of colon cancer?
Lancet. 2012 Apr 28;379(9826):1586; author reply 1587. doi: 10.1016/S0140-6736(12)60671-0. Epub 2012 Apr 26.
4
Does aspirin really reduce the risk of colon cancer?
Lancet. 2012 Apr 28;379(9826):1586-7; author reply 1587. doi: 10.1016/S0140-6736(12)60672-2. Epub 2012 Apr 26.
5
Daily aspirin reduces colorectal cancer incidence in patients with Lynch syndrome.
CA Cancer J Clin. 2012 May-Jun;62(3):143-4. doi: 10.3322/caac.21136. Epub 2012 Mar 12.
6
Aspirin Colorectal Cancer Prevention in Lynch Syndrome: Recommendations in the Era of Precision Medicine.
Genes (Basel). 2022 Mar 3;13(3):460. doi: 10.3390/genes13030460.
7
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
Lancet. 2011 Dec 17;378(9809):2081-7. doi: 10.1016/S0140-6736(11)61049-0. Epub 2011 Oct 27.
8
Aspirin may help colon cancer patients live longer.
Harv Health Lett. 2013 Jan;38(3):8.
9
Chemoprevention in Lynch syndrome.
Fam Cancer. 2013 Dec;12(4):707-18. doi: 10.1007/s10689-013-9650-y.
10
General practitioner attitudes towards prescribing aspirin to carriers of Lynch Syndrome: findings from a national survey.
Fam Cancer. 2017 Oct;16(4):509-516. doi: 10.1007/s10689-017-9986-9.
引用本文的文献
1
The Function of the Histamine H4 Receptor in Inflammatory and Inflammation-Associated Diseases of the Gut.
Int J Mol Sci. 2021 Jun 6;22(11):6116. doi: 10.3390/ijms22116116.
2
Genetic Deficiency of the Histamine H-Receptor Reduces Experimental Colorectal Carcinogenesis in Mice.
Cancers (Basel). 2020 Apr 8;12(4):912. doi: 10.3390/cancers12040912.
3
Transforming Cancer Prevention through Precision Medicine and Immune-oncology.
Cancer Prev Res (Phila). 2016 Jan;9(1):2-10. doi: 10.1158/1940-6207.CAPR-15-0406.
4
Aspirin Prevents Colorectal Cancer by Normalizing EGFR Expression.
EBioMedicine. 2015 May 1;2(5):447-455. doi: 10.1016/j.ebiom.2015.03.019.
5
Live imaging and gene expression analysis in zebrafish identifies a link between neutrophils and epithelial to mesenchymal transition.
PLoS One. 2014 Nov 5;9(11):e112183. doi: 10.1371/journal.pone.0112183. eCollection 2014.
6
Effects of aspirin on colorectal cancer related to lynch syndrome.
J Adv Pract Oncol. 2012 Nov;3(6):395-8.
7
Aspirin and other NSAIDs as chemoprevention agents in melanoma.
Cancer Prev Res (Phila). 2014 Jun;7(6):557-64. doi: 10.1158/1940-6207.CAPR-14-0018. Epub 2014 Apr 2.
8
Anti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrence.
Ther Adv Med Oncol. 2014 Mar;6(2):52-68. doi: 10.1177/1758834014521111.
9
Genetic testing strategies in newly diagnosed endometrial cancer patients aimed at reducing morbidity or mortality from lynch syndrome in the index case or her relatives.
PLoS Curr. 2013 Sep 16;5:ecurrents.eogt.b59a6e84f27c536e50db4e46aa26309c. doi: 10.1371/currents.eogt.b59a6e84f27c536e50db4e46aa26309c.
10
Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy.
Front Pharmacol. 2013 Jun 25;4:68. doi: 10.3389/fphar.2013.00068. eCollection 2013.
本文引用的文献
1
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
Lancet. 2011 Dec 17;378(9809):2081-7. doi: 10.1016/S0140-6736(11)61049-0. Epub 2011 Oct 27.
2
A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis.
Cancer Prev Res (Phila). 2011 May;4(5):655-65. doi: 10.1158/1940-6207.CAPR-11-0106.
3
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
4
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.
Lancet. 2011 Jan 1;377(9759):31-41. doi: 10.1016/S0140-6736(10)62110-1. Epub 2010 Dec 6.
5
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.
Lancet. 2010 Nov 20;376(9754):1741-50. doi: 10.1016/S0140-6736(10)61543-7. Epub 2010 Oct 21.
6
One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
Gastroenterology. 2010 Jun;138(7):2300-6. doi: 10.1053/j.gastro.2010.02.053. Epub 2010 Mar 2.
7
Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
J Natl Cancer Inst. 2009 Feb 18;101(4):256-66. doi: 10.1093/jnci/djn485. Epub 2009 Feb 10.
8
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
N Engl J Med. 2008 Dec 11;359(24):2567-78. doi: 10.1056/NEJMoa0801297.
9
10
Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.
JAMA. 2006 Sep 27;296(12):1507-17. doi: 10.1001/jama.296.12.1507.
Zotero 插件